© 2022 MJH Life Sciences™ and Contagion Live. All rights reserved.
Society of Infectious Diseases Pharmacists
Introducing “Bench to Bedside With SIDP,” a new column from the Society for Infectious Diseases Pharmacists covering everything from antimicrobial stewardship and pharmacokinetics/pharmacodynamics to mentorship, preceptorship, and more.
Latest from Society of Infectious Diseases Pharmacists
Precision Dosing of To-Marrow: Linezolid Therapeutic Drug Monitoring
November 03, 2022
Article
Emerging literature suggests therapeutic drug monitoring for this antimicrobial to minimize the risk for linezolid-associated toxicities while maintaining efficacy in select populations.
The Role of Rifampin in Bone and Joint Infections
September 07, 2022
Article
In the latest column from the Society of Infectious Diseases Pharmacists (SIDP), here is a discussion on the use of rifampin as an adjunctive antibiotic treatment for patients with diabetic foot osteomyelitis.
Clinical Considerations in Conducting Antifungal Susceptibility Testing
July 06, 2022
Article
Access to antifungal susceptibility testing (AFST) remains limited in the United States. Therefore, providers must recognize clinical situations where AFST will provide its greatest value. In the latest article from SIDP, infectious disease pharmacists offers some insights on this subject.
Ceftriaxone Dosing: Once or Twice Daily?
May 04, 2022
Article
In the latest column from SIDP, clinicians discuss that along with the once-daily dosing for many indications, there are also compelling indications for twice-daily dosing.
Antimicrobial Stewardship: How to Extend a Solid Handshake
March 02, 2022
Article
In the latest column from SIDP, handshake stewardship prioritizes face-to-face communication between frontline providers to enable feedback to assess the appropriateness of prescribed antimicrobials.
SPREADing the Love: The Importance of Mentorship in Pharmacy
January 05, 2022
Article
In the latest column from SIDP, the authors discuss having leaders to help navigate school and beyond.